Skip to content

Research

All Research Featured Research

Read: Adoption and Willingness to Pay for Emerging Dementia Therapies: Evidence From a Nationally Representative Survey

Journal Article

Adoption and Willingness to Pay for Emerging Dementia Therapies: Evidence From a Nationally Representative Survey

September 25, 2026

Featured Experts: J. Felipe Montano-Campos, PhD, Julie Zissimopoulos, PhD, Mireille Jacobson, PhD, Bryan Tysinger, PhD, Geoffrey Joyce, PhD

Read: Older Adults Have Strong Interest in Dementia Vaccine, Survey Finds

News

Older Adults Have Strong Interest in Dementia Vaccine, Survey Finds

September 21, 2026

Featured Experts: J. Felipe Montano-Campos, PhD, Geoffrey Joyce, PhD, Julie Zissimopoulos, PhD

Read: Alzheimer’s Science Is Advancing: California Can Keep It Moving With the ASAP Act

Perspective

Alzheimer’s Science Is Advancing: California Can Keep It Moving With the ASAP Act

September 16, 2026

Featured Experts: Joseph Grogan, JD

Read: Comments to CMS on Payment for Physician-Patient Clinical Trial Discussions

Comment Letter

Comments to CMS on Payment for Physician-Patient Clinical Trial Discussions

September 15, 2026

Featured Experts: Mireille Jacobson, PhD, Sidra Haye, PhD, Phyllis Barkman Ferrell, DrPH, MBA, Dana Goldman, PhD

Read: Fixing the Funnel: Stakeholder Insights on Alzheimer’s Disease Trial Recruitment

Issue Brief

Fixing the Funnel: Stakeholder Insights on Alzheimer’s Disease Trial Recruitment

August 7, 2026

Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA, Maria-Alice Manetas, Mireille Jacobson, PhD, Desi Peneva, MS

Read: Alzheimer’s Drugs Deserve a Second Opinion

Perspective

Alzheimer’s Drugs Deserve a Second Opinion

July 13, 2026

Featured Experts: Paul Aisen, MD, Joseph Grogan, JD

Read: Dementia Risk Factors Look Different Around the World, Large USC Study Finds

News

Dementia Risk Factors Look Different Around the World, Large USC Study Finds

July 13, 2026

Read: Dementia Will Cost the U.S. $818 Billion in 2026, USC-Led Study Finds

News

Dementia Will Cost the U.S. $818 Billion in 2026, USC-Led Study Finds

June 24, 2026

Featured Experts: Julie Zissimopoulos, PhD, Dana Goldman, PhD, Bryan Tysinger, PhD, Johanna Thunell, PhD

Read: The Economic Value of Americans Working One More Year

Issue Brief

The Economic Value of Americans Working One More Year

June 13, 2026

Featured Experts: Virat Agrawal, PhD, MS, Dana Goldman, PhD

Read: When It Comes to Retirement, a Year Can Change Everything

Perspective

When It Comes to Retirement, a Year Can Change Everything

June 13, 2026

Featured Experts: Dana Goldman, PhD

Read: Improving Clinical Trials Reporting in Medicare Claims

Perspective

Improving Clinical Trials Reporting in Medicare Claims

June 12, 2026

Featured Experts: Sidra Haye, PhD, Mireille Jacobson, PhD

Read: Alzheimer’s Biomarkers May Vary Across Populations—Complicating Trial Eligibility

Evidence Base

Alzheimer’s Biomarkers May Vary Across Populations—Complicating Trial Eligibility

May 21, 2026

Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA

Read: Experts Highlight How Technology Is Transforming Alzheimer’s Clinical Trial Recruitment

News

Experts Highlight How Technology Is Transforming Alzheimer’s Clinical Trial Recruitment

April 29, 2026

Read: Schaeffer Research Featured in Special Journal Issue on Alzheimer’s Care and Caregiving

News

Schaeffer Research Featured in Special Journal Issue on Alzheimer’s Care and Caregiving

April 7, 2026

Featured Experts: Julie Zissimopoulos, PhD

Read: Why Widespread Testing for Alzheimer’s Is Essential

Perspective

Why Widespread Testing for Alzheimer’s Is Essential

April 6, 2026

Featured Experts: Dana Goldman, PhD

Read: What Nearly 1,000 Studies Reveal About Alzheimer’s Clinical Trial Recruitment

Evidence Base

What Nearly 1,000 Studies Reveal About Alzheimer’s Clinical Trial Recruitment

March 18, 2026

Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA

Read: Evaluating Evidence-Based Recruitment Strategies for Alzheimer’s Disease and Related Dementias Clinical Trial Research: A Literature Review

Journal Article

Evaluating Evidence-Based Recruitment Strategies for Alzheimer’s Disease and Related Dementias Clinical Trial Research: A Literature Review

March 16, 2026

Featured Experts: Mireille Jacobson, PhD, Desi Peneva, MS, Phyllis Barkman Ferrell, DrPH, MBA, Maria-Alice Manetas, Rema Raman, PhD, Paul Aisen, MD, Dana Goldman, PhD

Read: Can We Prevent Alzheimer’s Disease Within a Decade?

News

Can We Prevent Alzheimer’s Disease Within a Decade?

March 5, 2026

Featured Experts: Paul Aisen, MD, Dana Goldman, PhD

Read: USC Initiative Awards Funding to Test AI-Driven Strategies to Accelerate Alzheimer’s Clinical Trials

News

USC Initiative Awards Funding to Test AI-Driven Strategies to Accelerate Alzheimer’s Clinical Trials

January 20, 2026

Featured Experts: Dana Goldman, PhD, Paul Aisen, MD

Read: How Medical Costs for People with Dementia Are Changing Over Time and Across the U.S.

Data Visualization

How Medical Costs for People with Dementia Are Changing Over Time and Across the U.S.

January 15, 2026

Featured Experts: Julie Zissimopoulos, PhD, Dana Goldman, PhD, Bryan Tysinger, PhD

1
2
3
4
…
13
14
15
Next →